John B. Cannon, Ph.D Prospects-for-Pharmaceutical-Treatment-of-AchondroplasiaDownload Achondroplasia is a form of …
Ascendis
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia
COPENHAGEN, Denmark, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company …